| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 04/06/2011 | EP2305302A2 Prevention and treatment of amyloidogenic disease |
| 04/06/2011 | EP2305236A1 Means of Ascertaining an Individual's Risk Profile for Atherosclerotic Disease |
| 04/06/2011 | EP2305235A1 Means of ascertaining an individual's risk profile for atherosclerotic disease |
| 04/06/2011 | EP2305214A1 Novel molecular assembly, molecular probe for molecular imaging and molecular probe for drug delivery system using the same, and molecular imaging system and drug delivery system |
| 04/06/2011 | EP2305213A2 The treatment of small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| 04/06/2011 | EP2303288A2 Conjugates of a polymer, a bisphosphonate and an anti-angiogenesis agent and uses thereof in the treatment and monitoring of bone related diseases |
| 04/06/2011 | EP2303246A1 Polymersomes, colloidosomes, liposomes, and other species associated with fluidic droplets |
| 04/06/2011 | EP2303114A1 Radiopharmaceutical imaging of neurodegenerative diseases |
| 04/06/2011 | EP2303001A1 Method for testing efficacy of treatment of neurologic disorders |
| 04/06/2011 | EP1430071B1 Secreted and cell surface genes expressed in benign and malignant colorectal tumors |
| 04/06/2011 | EP1404356B1 Method for designing cd10-activated prodrug compounds |
| 04/06/2011 | CN102002117A Branched chitosan derivative and preparation method thereof |
| 04/06/2011 | CN102002048A Water-soluble anionic bacteriochlorophyll derivatives and their uses |
| 04/06/2011 | CN102001985A Fullerene multi-nitrogen heterocyclic water-soluble derivatives as well as preparation method and application thereof |
| 04/06/2011 | CN102000364A Polymeric marker with high radiopacity for use in medical devices |
| 04/06/2011 | CN102000351A Method for preparing chitosan-modified magnetic liposomes |
| 04/06/2011 | CN102000350A Folic acid receptor targeting type nano gold particles and preparation method thereof |
| 04/06/2011 | CN102000349A Carbon nano tube/polymer/magnetic ferrate nano composite material and preparation method thereof |
| 04/06/2011 | CN102000348A Safety evaluation method for local use of medicament mucosa |
| 04/06/2011 | CN102000340A Targeted polymer medicament carrier and preparation method and application thereof |
| 04/06/2011 | CN101323022B Method for preparing gold magnetic core-shell nano-particle |
| 04/05/2011 | US7919274 Detecting position of particle in cell; obtain cell, administer with light emitting fusion protein, detect signal, image signal |
| 04/05/2011 | US7919071 Contrast agent |
| 04/05/2011 | CA2476350C Pyridyl sulfone derivatives as 5-ht receptor antagonists |
| 03/31/2011 | WO2011036191A2 Gold –coated magnetic glyconanoparticles functionalised with proteins for use as diagnostic and therapeutic agents |
| 03/31/2011 | WO2011012646A3 Non-invasive in vivo optical imaging method |
| 03/31/2011 | WO2010120905A3 Novel nano-probes for molecular imaging and targeted therapy of diseases |
| 03/31/2011 | WO2010118034A3 Cyclic peptide analogues for non-invasive imaging of pancreatic beta-cells |
| 03/31/2011 | WO2010093420A3 Ultrasmall superparamagnetic iron oxide nanoparticles and uses thereof |
| 03/31/2011 | US20110077684 Nucleus replacement based on injectable pva gels |
| 03/31/2011 | US20110077512 Biopsy marker composition and method of use |
| 03/31/2011 | US20110076237 Hydroxylated Contrast Enhancement Agents |
| 03/31/2011 | US20110076236 Compositions and methods of treatment using modulators of motoneuron diseases |
| 03/31/2011 | US20110076235 Genes, methods, and compositions related to neurogenesis and its modulation |
| 03/31/2011 | US20110076234 Peptides comprising an isodgr motif |
| 03/31/2011 | US20110076231 Temporary embolization using inverse thermosensitive polymers |
| 03/31/2011 | US20110076230 Novel Substituted Indoles |
| 03/31/2011 | CA2775324A1 Passivated nanoparticles |
| 03/30/2011 | EP2301968A2 Humanized monoclonal antibody HPAM4 |
| 03/30/2011 | EP2301587A2 KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy |
| 03/30/2011 | EP2301581A1 Production and use of novel peptide-based agents for use with B1-specific antibodies |
| 03/30/2011 | EP2300057A2 18f-labelled three-and four-carbon acids for pet imaging |
| 03/30/2011 | EP2054165B1 Method of covering self-assembled metal or inorganic surfaces with gem-bisphosphonic compounds and uses thereof |
| 03/30/2011 | EP1486785B1 Test agents for evaluating pharmacological effect of drug, and method and reagents for screening drug having excellent administration effect and/or little side effect from among drugs comprising enzymes, enzyme inhibitors or receptor ligands and/or prodrugs thereof |
| 03/30/2011 | CN101991868A Sterilizing, disinfecting and skin-moisturizing medical ultrasonic coupling agent and preparation method thereof |
| 03/30/2011 | CN101991867A Multi-mode targeted probe for early hepatic fibrosis diagnosis and preparation method thereof |
| 03/30/2011 | CN101991866A Nanometer gamma-Fe2O3 relaxation rate standard substance and preparation method thereof |
| 03/30/2011 | CN101991865A Method for detecting position of cancer or tumor by drinking medical chicken soup |
| 03/30/2011 | CN101991851A Ultrasound microbubble agent for treating tumors by low-intensity focused ultrasound and preparation method thereof |
| 03/30/2011 | CN101991569A Rhesus monkey temporal lobe epilepsy kindling model and drug screening method thereof |
| 03/29/2011 | US7915254 Photosensitizers for photodynamic therapy; killing tissue, cells; anticancer agents |
| 03/29/2011 | US7915248 Boronated metal-phthalocyanines, process for their preparation, pharmaceutical compositions comprising them and use thereof |
| 03/29/2011 | US7914998 Drug screening for identifying modulators of longevity; insulin-like signaling pathway; biodrug for treating aging; bioassay |
| 03/29/2011 | US7914769 Compounds for treating human papillomavirus |
| 03/29/2011 | CA2498891C Thermolabile liposome with a controlled release temperature |
| 03/29/2011 | CA2452845C Dye-sulfenates for dual phototherapy |
| 03/29/2011 | CA2412750C Substituted metal-phthalocyanines, their preparation and the use thereof |
| 03/29/2011 | CA2345276C Flt4 (vegfr-3) as a target for tumor imaging and anti-tumor therapy |
| 03/29/2011 | CA2165573C Anti-.alpha.v-integrin monoclonal antibody |
| 03/24/2011 | WO2011035279A2 Nanocarriers for imaging and therapy applications |
| 03/24/2011 | WO2011035140A1 Methods and compositions for delivery of contrast moieties to the lungs |
| 03/24/2011 | WO2011034892A2 Systems, methods, and devices for microbubbles |
| 03/24/2011 | WO2011034846A1 Use of alpha-methylglucoside (amg) as an indicator for glucose absorption and excretion |
| 03/24/2011 | WO2011034570A1 Diagnostic and therapeutic nanoparticles |
| 03/24/2011 | WO2011034183A1 Porphyrin compound |
| 03/24/2011 | WO2011009539A8 ε-POLYLYSINE CONJUGATES AND USE THEREOF |
| 03/24/2011 | WO2010128787A3 Gadolinium complex, method for preparing same, and mri contrast agent comprising same |
| 03/24/2011 | WO2010124257A3 Methods and kits for determining oxygen free radical (ofr) levels in animal and human tissues as a prognostic marker for cancer and other pathophysiologies |
| 03/24/2011 | WO2010108125A3 Psma-targeting compounds and uses thereof |
| 03/24/2011 | US20110072524 Transgenic Mouse Lacking Endogenous FVIII and VWF - A Model of Hemophilia A |
| 03/24/2011 | US20110070166 Reduced dye probes for the detection of radical oxygen species |
| 03/24/2011 | US20110070164 Post release modification of viral envelopes |
| 03/24/2011 | US20110070163 Cancer cell migration and cancer cell invasion inhibitor |
| 03/24/2011 | US20110070162 Rna interference mediating small rna molecules |
| 03/24/2011 | US20110070155 Anti-CD74 Immunoconjugates and Methods |
| 03/24/2011 | US20110070154 Artificial cells |
| 03/23/2011 | EP2299268A2 Methods and compositions for diagnosing hepatocellular carcinoma |
| 03/23/2011 | EP2298362A1 Responsive paramagnetic MRI contrast agents |
| 03/23/2011 | EP2298361A2 Ocular diagnosis of Alzheimer's disease |
| 03/23/2011 | EP2297178A2 Peptide analogs of alpha-melanocyte stimulating hormone |
| 03/23/2011 | EP2296620A2 Magnetic microbubbles, methods of preparing them and their uses |
| 03/23/2011 | EP1631305B1 Sincalide formulations |
| 03/23/2011 | CN101987203A Method for preparing magnetic gene-loaded lipid ultrasonic microbubble contrast medium |
| 03/23/2011 | CN101987202A Preparation of dendrimer/ gold-silver alloy nanoparticle with computed tomography (CT) radiography function |
| 03/23/2011 | CN101987201A Medical ultrasonic probe sterilizing gel and preparation method thereof |
| 03/23/2011 | CN101537193B Vesicle monoamine transporter target bound drug and preparation method thereof |
| 03/23/2011 | CN101310850B Preparation method and use method of polylactic acid tree-like molecule-modified magnetic nano particles |
| 03/23/2011 | CN101245002B Process for producing steady iodination vegetable oil, iodination vegetable oil fatty acid ethyl ester |
| 03/22/2011 | US7910323 Methods for identifying the effect of a drug agent on the metabolism of sugars and fats in an individual |
| 03/22/2011 | US7910099 Antibodies to VLA-1 |
| 03/22/2011 | US7910093 administering to mammals a Sindbis virus comprising gene that code detectable labels, concurrently with anticarcinogenic agents, and analyzing the amount of cancer cells in the body of the mammal |
| 03/22/2011 | CA2317921C Preparation of a lipid blend and a phospholipid suspension containing the lipid blend |
| 03/17/2011 | WO2011031999A2 Multi-component nanoparticle structure having detectable magnetic resonance properties |
| 03/17/2011 | WO2011031955A2 Optical monitoring of leukemia |
| 03/17/2011 | WO2011031667A1 Methods for diagnosis and intervention of hepatic disorders |
| 03/17/2011 | WO2011031073A2 Novel tetra-aza macrocyclic compound, method for preparing same, and use thereof |
| 03/17/2011 | WO2011031042A2 Pegylated triiodinated aryl compound, and x-ray contrast agent comprising same |
| 03/17/2011 | WO2011030160A1 Detection of mycobacteria |
| 03/17/2011 | WO2011029854A1 13c-mr detection using hyperpolarised 13c-fructose |
| 03/17/2011 | WO2011011105A3 Traceable retinoid acid for imaging, disease prevention and therapy |